ABL Awarded Seven-Year NIH Contract for Continued Support in HIV Prevention Products

Media Type
Article
Publish or Event Date
Research Institution
Advanced BioScience Laboratories
Short Title
ABL Awarded Seven-Year NIH Contract for Continued Support in HIV Prevention Products
Content Coordinator
Content Manager

Aphios Awarded an NIH Grant to Develop a Double Encapsulated mRNA Vaccine For COVID-19 and Other Diseases

Media Type
Article
Publish or Event Date
Research Institution
Aphios
Short Title
Aphios Awarded a Grant to Develop a Double Encapsulated mRNA Vaccine For COVID-19
Content Coordinator
Content Manager

Beyond Aesthetics—a Visualization Tool for better Vaccines

Deadly Virus Structures Point Toward New Avenues for Vaccine Design

Genetic Change Increased Bird Flu Severity During U.S. Spread

Media Type
Article
Publish or Event Date
Research Institution
St. Jude Children’s Research Hospital
Short Title
Genetic Change Increased Bird Flu Severity During U.S. Spread
Content Coordinator
Content Manager

Notice of Special Interest (NOSI)—Advancing Biomedical Research in Pulmonary Non-Tuberculous Mycobacterial (NTM) Infections

Notice of Special Interest (NOSI)—HIV Cure-Related Research in Varied Populations

Combating Antibiotic-Resistant Bacteria Interdisciplinary Research Units (CARBIRU)

The Combating Antibiotic-Resistant Bacteria Interdisciplinary Research Units (CARBIRUs) are multidisciplinary research centers focused on bacterial pathogens for which antibiotic resistance poses a significant public health concern, as designated by the CDC’s 2019 Report on Antibiotic Resistance Threats in the United States. Each center brings together investigators from multiple disciplines to investigate non-antibiotic alternative treatment and preventive strategies, including bacteriophage, monoclonal antibodies, ligand mimetics, and defined microbial consortia; poorly understood resistance mechanisms contributing to bacterial persistence and antibiotic treatment failure; and identification and validation of novel bacterial targets for antibiotic intervention.

Main Areas of Focus

The CARBIRU program supports fundamental, collaborative research ranging from discovery to early development research activities such as the:

  • Discovery and validation of viable preventative, therapeutic, or diagnostic targets
  • Identification and characterization of host factors involved in susceptibility or response to infection and/or resistance
  • Elucidation of known or evolving mechanisms of antibiotic resistance and strategies to prevent emergence of resistance
  • Identification and development of novel approaches to combat antibiotic-resistant infections
  • Understanding the role of the microbiome and antibiotic-mediated dysbiosis in the development of resistant infections

Contact Information

Locations
Content Coordinator
No local navigation
Off

June 2023 Trans-Divisional Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.

Note: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

Fiscal Year (FY) 2024 Concepts

June 2023 DMID Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.

Note: Council approval does not guarantee that a concept will become an initiative.